首页> 美国卫生研究院文献>Journal of Clinical Medicine >Acute Kidney Injury Patterns Following Transplantation of Steatotic Liver Allografts
【2h】

Acute Kidney Injury Patterns Following Transplantation of Steatotic Liver Allografts

机译:脂肪性肝同种异体移植后的急性肾脏损伤模式

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background: Steatotic grafts are increasingly being used for liver transplant (LT); however, the impact of graft steatosis on renal function has not been well described. Methods: A total of 511 allografts from Mayo Clinic Arizona and Minnesota were assessed. We evaluated post-LT acute kidney injury (AKI) patterns, perioperative variables and one-year outcomes for patients receiving moderately steatotic allografts (>30% macrovesicular steatosis, = 40) and compared them to non-steatotic graft recipients. Results: Post-LT AKI occurred in 52.5% of steatotic graft recipients versus 16.7% in non-steatotic recipients ( < 0.001). Ten percent of steatotic graft recipients required new dialysis post-LT ( = 0.003). At five years, there were no differences for AKI vs. no AKI patient survival (HR 0.95, 95% CI 0.08–10.6, = 0.95) or allograft survival (HR 1.73, 95% CI 0.23–13.23, = 0.59) for those using steatotic grafts. Lipopeliosis on biopsy was common in those who developed AKI (61.0% vs. 31.6%, = 0.04), particularly when the Model for End-Stage Liver Disease (MELD) was ≥20 (88.9%; = 0.04). Lipopeliosis was a predictor of post-LT AKI (OR 6.0, 95% CI 1.1–34.6, = 0.04). Conclusion: One-year outcomes for moderately steatotic grafts are satisfactory; however, a higher percentage of post-LT AKI and initiation of dialysis can be expected. Presence of lipopeliosis on biopsy appears to be predictive of post-LT AKI.
机译:背景:脂肪变性移植物越来越多地用于肝移植(LT)。然而,关于移植物脂肪变性对肾功能的影响尚未得到很好的描述。方法:共评估了来自亚利桑那州梅奥诊所和明尼苏达州的511个同种异体移植物。我们评估了接受中度脂肪变性同种异体移植(> 30%大泡脂肪变性,= 40)的患者的LT术后急性肾损伤(AKI)模式,围手术期变量和一年结局,并将其与非脂肪变性移植受者进行了比较。结果:LT后AKI发生在52.5%的脂肪变性移植受者中,而16.7%发生在非脂肪变性的移植物中(<0.001)。百分之十的脂肪变性移植受者需要在LT后进行新的透析(= 0.003)。五年后,使用AKI的患者与未使用AKI的患者生存率(HR 0.95,95%CI 0.08–10.6,= 0.95)或同种异体移植的生存率(HR 1.73,95%CI 0.23–13.23,= 0.59)没有差异。脂肪变性移植物。发生AKI的患者在活检中出现脂皮病很常见(61.0%比31.6%,= 0.04),特别是当终末期肝病模型(MELD)≥20(88.9%; = 0.04)时。脂溢病是LT AKI后的预测指标(OR 6.0,95%CI 1.1–34.6,= 0.04)。结论:中度脂肪变性移植物的一年预后令人满意。但是,可以预期更高比例的LT后AKI和开始透析。活检中脂溢病的存在似乎预示了LT AKI后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号